Maternal KIR in combination with paternal HLA-C2 regulate human birth weight

Journal of Immunology

Volumn 192, Issue 11, 2014, Pages 5069-5073

  Hiby, Susan E ^a   Apps, Richard ^b,c   Chazara, Olympe ^a   Farrell, Lydia E ^a   Magnus, Per ^d   Trogstad, Lill ^d   Gjessing, Hakon K ^d   Carrington, Mary ^b,c   Moffett, Ashley ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND;

ARTICLE; BIRTH WEIGHT; COHORT ANALYSIS; GENE; GENOTYPE; HUMAN; IMMUNE SYSTEM; KIR2DS1 GENE; MATERNAL KIR GENE; NEWBORN MORBIDITY; PATERNAL HLA C2 GENE; PREGNANCY; PRIORITY JOURNAL; UNITED KINGDOM;

BIRTH WEIGHT; FEMALE; HLA-C ANTIGENS; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; RECEPTORS, KIR;

EID: 84901287414     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400577     Document Type: Article

References (32)

1. Cavalli-Sforza, L., and W. F. Bodmer. 1971. The Genetics of Human Populations. Freeman , San Francisco.
2. Rosenberg, M. 1988. Birth weights in three Norwegian cities, 1860-1984. Secular trends and influencing factors. Ann. Hum. Biol. 15: 275-288.
3. Trevathan, W. R. 2011. Human birth: An Evolutionary Perspective. Transaction Books, Piscataway, NJ.
4. Karn, M. N., and L. S. Penrose. 1951. Birth weight and gestation time in relation to maternal age, parity and infant survival. Ann. Eugen. 16: 147-164.
5. Steer, P. J., M. P. Little, T. Kold-Jensen, J. Chapple, and P. Elliott. 2004. Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study. BMJ 329: 1312-1317.
6. Magnus, P., H. K. Gjessing, A. Skrondal, and R. Skjaerven. 2001. Paternal contribution to birth weight. J. Epidemiol. Community Health 55: 873-877.
7. Rice, F., and A. Thapar. 2010. Estimating the relative contributions of maternal genetic, paternal genetic and intrauterine factors to offspring birth weight and head circumference. Early Hum. Dev. 86: 425-432.
8. Horikoshi, M., H. Yaghootkar, D. O. Mook-Kanamori, U. Sovio, H. R. Taal, B. J. Hennig, J. P. Bradfield, B. St Pourcain, D. M. Evans, P. Charoen, et al; Meta-Analyses of Glucose- and Insulin-related traits Consortium (MAGIC); Early Growth Genetics (EGG) Consortium. 2013. New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat. Genet. 45: 76-82.
9. Moffett, A., and C. Loke. 2006. Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 6: 584-594.
10. Moffett-King, A. 2002. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2: 656-663.
11. Apps, R., S. P. Murphy, R. Fernando, L. Gardner, T. Ahad, and A. Moffett. 2009. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127: 26-39.
12. Hiby, S. E., R. Apps, A. M. Sharkey, L. E. Farrell, L. Gardner, A. Mulder, F. H. Claas, J. J. Walker, C. W. Redman, L. Morgan, et al. 2010. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLAC2. J. Clin. Invest. 120: 4102-4110.
13. Parham, P. 2005. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5: 201-214.
14. Parham, P., and A. Moffett. 2013. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat. Rev. Immunol. 13: 133-144.
15. Norwitz, E. R. 2006. Defective implantation and placentation: laying the blueprint for pregnancy complications. Reprod. Biomed. Online 13: 591-599.
16. Pijnenborg, R., L. Vercruysse, and M. Hanssens. 2006. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27: 939-958.
17. Hiby, S. E., J. J. Walker, K. M. O'shaughnessy, C. W. G. Redman, M. Carrington, J. Trowsdale, and A. Moffett. 2004. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200: 957-965.
18. Hiby, S. E., L. Regan, W. Lo, L. Farrell, M. Carrington, and A. Moffett. 2008. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum. Reprod. 23: 972-976.
19. Magnus, P., L. M. Irgens, K. Haug, W. Nystad, R. Skjaerven, and C. Stoltenberg; MoBa Study Group. 2006. Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Int. J. Epidemiol. 35: 1146-1150.
20. Rønningen, K. S., L. Paltiel, H. M. Meltzer, R. Nordhagen, K. K. Lie, R. Hovengen, M. Haugen, W. Nystad, P. Magnus, and J. A. Hoppin. 2006. The biobank of the Norwegian Mother and Child Cohort Study: a resource for the next 100 years. Eur. J. Epidemiol. 21: 619-625.
21. R Core Team. 2013. R: A Language and Environment for Statistical Computing, version 2.15. R Foundation for Statistical Computing, Vienna, Austria. Available at: http://www.r-project.org
22. Oken, E., K. P. Kleinman, J. Rich-Edwards, and M. W. Gillman. 2003. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr. 3: 6.
23. Klebanoff, M. A., B. R. Mednick, C. Schulsinger, N. J. Secher, and P. H. Shiono. 1998. Father's effect on infant birth weight. Am. J. Obstet. Gynecol. 178: 1022-1026.
24. Madeja, Z., H. Yadi, R. Apps, S. Boulenouar, S. J. Roper, L. Gardner, A. Moffett, F. Colucci, and M. Hemberger. 2011. Paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth. Proc. Natl. Acad. Sci. USA 108: 4012-4017.
25. Höglund, P., and P. Brodin. 2010. Current perspectives of natural killer cell education by MHC class I molecules. Nat. Rev. Immunol. 10: 724-734.
26. Hilton, H. G., L. Vago, A. M. Older Aguilar, A. K. Moesta, T. Graef, L. Abi- Rached, P. J. Norman, L. A. Guethlein, K. Fleischhauer, and P. Parham. 2012. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3. J. Immunol. 189: 1418-1430.
27. Xiong, S., A. M. Sharkey, P. R. Kennedy, L. Gardner, L. E. Farrell, O. Chazara, J. Bauer, S. E. Hiby, F. Colucci, and A. Moffett. 2013. Maternal uterine NK cellactivating receptor KIR2DS1 enhances placentation. J. Clin. Invest. 123: 4264-4272.
28. Venstrom, J. M., G. Pittari, T. A. Gooley, J. H. Chewning, S. Spellman, M. Haagenson, M. M. Gallagher, M. Malkki, E. Petersdorf, B. Dupont, and K. C. Hsu. 2012. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. N. Engl. J. Med. 367: 805-816.
29. Robert Peter, J., J. J. Ho, J. Valliapan, and S. Sivasangari. 2012. Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth. Cochrane Database Syst. Rev. 7: CD008136.
30. Oliver, M., G. McNally, and L. Leader. 2013. Accuracy of sonographic prediction of birth weight. Aust. N. Z. J. Obstet. Gynaecol. 53: 584-588.
31. Curti, A., M. Zanello, I. De Maggio, E. Moro, G. Simonazzi, N. Rizzo, and A. Farina. 2013. Multivariable evaluation of term birth weight: a comparison between ultrasound biometry and symphysis-fundal height. J. Matern. Fetal Neonatal Med. 10.3109/14767058.2013.858241.
32. King, A., D. S. Allan, M. Bowen, S. J. Powis, S. Joseph, S. Verma, S. E. Hiby, A. J. McMichael, Y. W. Loke, and V. M. Braud. 2000. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur. J. Immunol. 30: 1623-1631.